AMLX
Amylyx Pharmaceuticals Inc
Biopharmaceutical company developing treatments for neurodegenerative diseases and endocrine conditions
CUSIP: 03237H101HealthcareUS1 holder
Recent Activity
2024Q1
1 sell
-2.96M shares
-2.96M shares
Loading more activity...